StaphOff has developed a completely unique approach to fighting staphylococcal infections using a first-in-class heptapeptide known as RNAIII Inhibiting Peptide (RIP) or CEN-101, and non-peptide analogues like CEN-103.

Biotechnology

StaphOff Biotech

StaphOff Biotech's headquarters in Hopkinton, MA, United States

Naomi Balaban

Charles Mitchell

Richard Breitling

Alan Laverson

Florencia Lopez Leban

Randall Wolcott

John P. Kennedy

Donald Griffith

StaphOff Biotech's Leadership Team includes Charles Mitchell and 4 others.

About

People (5)

Alan Laverson

Charles Mitchell

Florencia Lopez Leban

Naomi Balaban

Richard Breitling

Jobs